Wed, November 8, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Eric Larson Downgraded (ANDE) to Hold on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Kenneth Zaslow Maintained (ANDE) at Hold with Decreased Target to $34 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Craig Ellis Maintained (CAMT) at Strong Buy with Increased Target to $7.5 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Chris Woronka Maintained (CAR) at Strong Buy with Decreased Target to $48 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Sarah Dewitt Upgraded (CB) to Buy on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Brian Bedell Maintained (CBOE) at Hold with Increased Target to $108 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Scott Valentin Upgraded (AJX) to Strong Buy on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Simeon Gutman Maintained (AAP) at Buy with Increased Target to $100 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Edward Nash Initiated (ABEO) at Strong Buy and Held Target at $650 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Sameet Sinha Maintained (APPS) at Strong Buy with Increased Target to $2 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Jeffrey Silber Maintained (APEI) at Hold with Increased Target to $20 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Louis Miscioscia Initiated (ACN) at Strong Buy and Held Target at $165 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Elliott Schlang Upgraded (ZBRA) to Strong Buy on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Michael Graham Maintained (Z) at Strong Buy and Held Target at $52 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Deepak Mathivanan Maintained (Z) at Hold with Increased Target to $46 on, Nov 8th, 2017
[ Wed, Nov 08th 2017 ]: WOPRAI
Michael Graham Maintained (Z) at Strong Buy with Increased Target to $53 on, Nov 8th, 2017
Tue, November 7, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
A.J. Rice Initiated (CCRN) at Hold and Held Target at $13 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Gordon Gray Downgraded (XOM) to Sell on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Scott Goldman Maintained (TMUS) at Strong Buy with Decreased Target to $77 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Ross Law Initiated (SPR) at Strong Buy and Held Target at $100 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Michael Blum Downgraded (TRGP) to Hold on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Mark May Upgraded (TRVG) to Strong Buy on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Duffy Fischer Maintained (TSE) at Hold with Increased Target to $78 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Sam Poser Upgraded (UAA) to Hold on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
John Vinh Maintained (SWKS) at Buy with Increased Target to $125 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Joseph France Maintained (DOC) at Buy with Increased Target to $21 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
John Roberts Maintained (ASH) at Strong Buy with Increased Target to $78 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Brett Feldman Upgraded (ATUS) to Strong Buy on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Derryn Maade Upgraded (AU) to Strong Buy on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Omar Sheikh Maintained (AMC) at Sell with Decreased Target to $89 on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Howard Rubel Upgraded (BAH) to Strong Buy on, Nov 7th, 2017
[ Tue, Nov 07th 2017 ]: WOPRAI
Michael Schmidt Maintained (ABUS) at Hold with Increased Target to $5.5 on, Nov 7th, 2017
Mon, November 6, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Chris Parkinson Maintained (AXTA) at Buy with Increased Target to $37 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
John Murphy Maintained (AXL) at Sell with Increased Target to $13 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Andrew Obin Initiated (AZPN) at Hold and Held Target at $67 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Brian Meredith Maintained (ALL) at Hold with Increased Target to $102 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Brett Hoselton Maintained (ALV) at Buy with Increased Target to $146 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Ian Somaiya Maintained (BIIB) at Buy with Increased Target to $386 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Romit Shah Maintained (AVGO) at Strong Buy with Increased Target to $30 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
John Roberts Upgraded (DOC) to Strong Buy on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Mickey Schlelen Upgraded (SLRC) to Strong Buy on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Bascome Majors Upgraded (TRN) to Buy on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Josh Schimmer Downgraded (BLUE) to Hold on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Andrew Strelzik Maintained (BLMN) at Buy with Decreased Target to $24 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Jason West Maintained (BLMN) at Hold with Decreased Target to $18 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Michael Weinstein Maintained (BKH) at Buy with Decreased Target to $66 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
Josh Beck Maintained (SQ) at Buy with Increased Target to $40 on, Nov 6th, 2017
[ Mon, Nov 06th 2017 ]: WOPRAI
John Hodulik Maintained (TMUS) at Strong Buy with Decreased Target to $70 on, Nov 6th, 2017

Michael Schmidt Maintained (ABUS) at Hold with Increased Target to $5.5 on, Nov 7th, 2017

Michael Schmidt of Leerink Swann, Maintained "Arbutus Biopharma Corporation" (ABUS) at Hold with Increased Target from $4 to $5.5 on, Nov 7th, 2017.

Michael, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30